Chronic lung disease: The role of oxidative stress

Biology of the Neonate

Volumn 74, Issue SUPPL. 1, 1998, Pages 21-28

  Saugstad, Ola Didrik ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antioxidants; Bronchopulmonary dysplasia; Chronic lung disease; Oxidative stress; Oxygen free radicals; Preterm infant

Indexed keywords

ANTIOXIDANT; FREE RADICAL; LUNG SURFACTANT;

CHRONIC LUNG DISEASE; CONFERENCE PAPER; HYPEROXIA; INFLAMMATION; LUNG DYSPLASIA; OXIDATIVE STRESS; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; BRONCHOPULMONARY DYSPLASIA; CHRONIC DISEASE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG DISEASES; OXIDATIVE STRESS; PULMONARY SURFACTANTS;

EID: 0031694722     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047031     Document Type: Conference Paper

References (67)

1. Saugstad OD: Bronchopulmonary dysplasia and oxidative stress: Are we closer to an understanding of the pathogenesis of BPD? Acta Paediatr 1997;86:1277-1282.
2. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, Ikonen RS: Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized placebo-controlled multicenter study. Pediatrics 1994; 93:730-736.
3. Northway WH, Rosan RC, Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276: 357-368.
4. O'Brodovich HM, Mellins RB: Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. Am Rev Respir Dis 1985;132:694-709.
5. Saugstad OD: Oxygen toxicity in the neonatal period. Acta Paediatr Scand 1990;79:881-892.
6. Saugstad OD, Gluck L: Plasma hypoxanthine levels in newborn infants: A specific indicator of hypoxia. J Perinat Med 1982;10:266-272.
7. Saugstad OD, Hallman M, Abraham J, Cochrane CG, Espstein B, Gluck L: Hypoxanthine and oxygen induced lung injury: A basic mechanism of tissue damage? Pediatr Res 1984;18:501-504.
8. Saugstad OD: Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production. Pediatr Res 1988; 23:143-150.
9. 2-rich environment: The antioxidant enzymes in the developing rabbit lung. Pediatr Res 1984;18:240-244.
10. Yam J, Frank L, Roberts RJ: Age-related development of pulmonary antioxidant enzymes in the rat. Proc Soc Exp Biol Med 1978;157:293-296.
11. Frank L, Sosenko IR: Prenatal development of lung antioxidant enzymes in four species. J Pediatr 1987;110:106-110.
12. Tanswell AK, Freeman BA: Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat. I. Developmental profiles. Pediatr Res 1984;18:584-587.
13. Gerdin E, Tyden O, Erikson UJ: The development of antioxidant enzymatic defense in the perinatal rat lung. Activities of Superoxide dismutase, gluthathione peroxidase and catalase. Pediatr Res 1984;19: 687-691.
14. Hayashibe H, Asayama K, Dobashi K, Kato K: Prenatal development of antioxidant enzymes in the rat lung, kidney, and heart: Marked increase in immunoreactivity Superoxide dismutase, glutathione peroxidase, and catalase in the kidney. Pediatr Res 1990;27:472-475.
15. Frank L, Sosenko IRS: Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: Increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res 1991;29:292-296.
16. Chen Y, Whitney PL, Frank L: Comparative responses of premature versus full-term newborn rats to prolonged hyperoxia. Pediatr Res 1994;35:233-237.
17. Phylactos AC, Leaf AA, Costeloe K, Crawford MA: Erythrocyte copper/ zinc Superoxide dismutase exhibits reduced activity in preterm and low-birthweight infants at birth. Acta Paediatr 1995;84:1421-1425.
18. Pallardo FV, Sastre J, Asensi M, Rodrigo F, Estrela JM, Vina J: Physiological changes in glutathione metabolism in foetal and newborn rat liver. Biochem J 1991;274-891-893.
19. Vina J, Vento M, Garcia-Sala F, Puertes IR, Gasco E, Sastre J, Asensi M. Pallardo FV: L-Cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am J Clin Nutr 1995;61:1067-1069.
20. Saugstad OD: Mechanisms of tissue injury by oxygen radicals: Implications for neonatal disease. Acta Paediatr 1996;85:1-4
21. Johnson KJ, Fantone JC, Kaplan J, Ward PA: In vivo damage of rat lungs by oxygen metabolites. J Clin Invest 1981;67:983-993.
22. Saugstad OD, Hallman M, Becher G, Oddoy A, Lachmann B: Respiratory failure caused by intratracheal saline: Additive effect of xanthine oxidase. Biol Neonate 1988;54:61-67.
23. Saugstad OD, Becher G, Grossmann M, Merker G, Oddoy A, Lachmann B: Acute and chronic effects of xanthine oxidase on lung thorax-compliance in guinea pigs. Intensive Care Med 1987;13:30-32.
24. Russell GAB, Cooke RWI: Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child 1995;73:F27-F31.
25. Wilborn A, Evers LB, Canada AT: Oxygen toxicity to the developing lung of the mouse: Role of reactive oxygen species. Pediatr Res 1996; 40:225-232.
26. Han RN, Buch S, Tseu I, Young J, Christie NA, Frndova H, Lye SJ, Post M, Tanswell AK: Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res 1996;39:921-929.
27. Kelly FJ, Lubec G: Hyperoxic injury of immature guinea pig lung is mediated via hydroxyl radicals. Pediatr Res 1995;38:286-291.
28. Coalson JJ: Experimental models of bronchopulmonary dysplasia. Biol Neonate 1997;71(suppl 1):35-38.
29. Clerch LB, Wright AE, Coalson JJ: Lung manganese Superoxide dismutase protein expression increases in the baboon model of bronchopulmonary dysplasia and is regulated at a posttranscriptional level. Pediatr Res 1996;39:253-258.
30. Pitkanen OM, Hallman M, Andersson SM: Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birth weight infants. J Pediatr 1990;116: 760-764.
31. Varsila E, Pitkanen O, Hallman M, Andersson S: Immaturity-dependent free radical activity in premature infants. Pediatr Res 1994;36: 55-59.
32. Varsila E, Hallman M, Andersson S: Free-radical-induced lipid peroxidation during the early neonatal period. Acta Paediatr 1994;83:692-695.
33. Gladstone IM, Levine RL: Oxidation of proteins in neonatal lungs. Pediatrics 1994;93:764-768.
34. Varsila E, Pesonen E, Andersson S: Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr 1995;84:1296-1299.
35. Ogihara T, Okamoto R, Kim H-S, Nagai A, Morinobu T, Moji H, Kamegai H, Hirano K, Ogihara H, Tamai H, Mino M: New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 1996;39:117-119.
36. 2 and lipid peroxidation in the lungs of premature infants (abstract). Pediatr Res 1996;39:329.
37. Lubec G, Widness JA, Hayde M, Menzel D, Pollak A: Hydroxyl radical generation in oxygen-treated infants. Pediatrics 1997;100:700-704.
38. Babior BM, Kipnes RS, Curnutte JT Biological defense mechanisms. The production of superoxide: A potential bactericidal agent. J Clin Invest 1973;52:741-744.
39. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK, Gluck L: Elastase and alpha I-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983;72: 656-666.
40. Groneck P, Speer CP: Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995;73:F1-F3.
41. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP: Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994;93:712-718.
42. Ogden B, Murphy S, Saunders G, Pathak D, Johnson J: Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984;130:817-821.
43. Kojima T, Sasai M, Kobayashi Y: Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia. Lancet 1993;342:1023-1024.
44. Etzioni A: Adhesion molecules: Their role in health and disease. Pediatr Res 1996;39:191-198.
45. Fellman V, Raivio KO: Reperfusion injury as a mechanism of brain damage after perinatal asphyxia. Pediatr Res 1997;41:599-606.
46. Stefano JL, Spear ML, Pearlman SA, Fawcett P, Proujanski R: Soluble Interleukin-2-receptor levels in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1992; 14:58-62.
47. Moison RM, de Beaufort AJ, Haasnot AA, Dubbelman TM, van Zoeren-Grobben D, Berger HM: Uric acid and ascorbic acid redox ratios in plasma and tracheal aspirate of preterm babies with acute and chronic lung disease. Free Radic Biol Med 1997;23:226-234.
48. Bracci R: Free oxygen radicals and surfactant. Biol Neonate 1997;71 (suppl 1):23-27.
49. Moison RMW, Palinckx JJS, Roest M, Houdkamp E, Berger HM: Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies. Lancet 1993;341:79-82.
50. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S: Mechanisms of peroxynitrite-induced injury to lung surfactants. Am J Physiol 1993;265:L555-L564.
51. Hallman M: Molecular interactions between nitric oxide and lung surfactant. Biol Neonate 1997;71(suppl 1):44-48.
52. Haagsman HP: Oxidative damage of the pulmonary surfactant system. Semin Neonatol 1998, in press.
53. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
54. Holm BA, Matalon S, Finkelstein JN, Notter RH: Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol 1988;65:2672-2678.
55. Nogee LM, Wispe JR, Clark JC, Weaver T, Whitsett JA: Increased expression of pulmonary surfactant proteins in oxygen exposed rats. Am J Respir Cell Mol Biol 1991;4:102-107.
56. 2-mediated injury of type II cell surfactant metabolism and protection with PEG-catalase. Am J Physiol 1991;261:C751-C757.
57. Novotny WE, Hudak BB, Matalon S, Holm BA: Hyperoxic lung injury reduces exogenous surfactant clearance in vivo. Am J Respir Crit Care Med 1995;151:1843-1847.
58. Dhar V, Hallman M, Lappalainen U, Bry K: Interleukin-1-alpha up-regulates the expression of surfactant protein-A in rabbit lung explants. Biol Neonate 1997;71:46-52.
59. Nilsson R, Grossmann G, Berggren P, Robertson B: Surfactant treatment in experimental hyaline membrane disease. Eur J Respir Dis 1981;62:441-449.
60. Robertson B, Berry D, Curstedt T, Grossmann G, Ikegami M, Jacobs H, Jobe A, Jones S: Leakage of protein in the immature rabbit lung: Effect of surfactant replacement. Repsir Physiol 1985;61:265-276.
61. Chen Y, Sosenko IL, Frank L: Positive regulation of pulmonary antioxidant enzyme gene expression by prenatal thyrotropin releasing hormone plus dexamethasone treatment in premature rats exposed to hyperoxia. Pediatr Res 1995;37: 611-616.
62. Rosenfeld W, Evans H, Concepcion L. Jhaven R, Schaffer H, Friedman A: Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 1984;105: 781-785.
63. Davis JM, Rosenfeld WN, Sanders RJ, Gonenne A: Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol 1993;74:2234-2241.
64. Davis JM, Rosenfeld WN, Richter SE, Parad RP, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, Kassem N, Edwards L, Tierny J, Horowitz S: Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997;100:24-30.
65. Shenai JP, Kennedy KA, Stahlman MT: Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987;111:269-277.
66. Ehrenkranz RA, Ablow RC, Warshaw JB: Effect of vitamin E on the development of oxygen induced lung injury in neonates. Ann NY Acad Sci 1982;393:452-466.
67. Watts JL, Milner R, Zipursky A, Paes B, Ling E, Gill G, Fletcher B, Rand C: Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1.500g birth weight. Eur Respir J 1991;4:188-190.